Local label deviation review that reads every label against the CCDS by meaning, not by matching words
Every local label checked against the CCDS meaning by meaning, in its language.
See one case, screen by screen ↓It is the check that every local label — SmPC, USPI, bula, package insert, IPP, monograph — says what the CCDS says, and that every difference has a reason on file. Local Label Deviation Review reads each label in its own language, back-translates it, pairs every sentence with its CCDS meaning and classifies each row as aligned, acceptable deviation or unjustified, for the medical risk assessor to decide.
How to choose AI solutions for life sciences →
Updated
Every local label must say what the CCDS says, unless a reason is on file: health-authority-mandated text, a national template rule, local data. But each local label — SmPC, USPI, bula, package insert, IPP, monograph — is written into a national template, often in another language, and meaning drifts on the way — a warning softened, a number changed in a translation round, a contraindication dropped. Checking it today means a vendor back-translation, a side-by-side in Word and a deviation tracker in a spreadsheet, label by label.
The deviations that matter are the hardest to see. A word-level check passes a sentence that keeps 85% of its words and turns “interrupt treatment” into “use with caution”. Justifications sit scattered by country and product, and one approved for another product gets applied by habit. The register lags the labels — and a softened warning in §4.3–4.4 is a patient-safety issue that can also become an inspection finding.
Estimated hours of people time on one label's first pass, by hand and with the agents — the solution's own estimate.
Six agents read, back-translate, pair and classify every local label and draft each fix; the medical risk assessor decides every deviation.
Veltrimab, a biologic for plaque psoriasis and Crohn's disease, has CCDS 15.0, approved Sep 2, and an audit wave of 24 local labels in 15 languages. The register is due at the Nov 20 inspection-readiness review. On Oct 7 the Brazil bula arrives. Here is what happens next, screen by screen, in the working solution.
Ana Ribeiro, affiliate regulatory in Brazil, sends Bula profissional v7: 18 pages, reformatted into the national bula template. On the Compare screen every row is a CCDS 15.0 meaning in English beside the Portuguese text as the label reads, with the page it sits on. A rail across the top shows all 24 markets with a status dot each. The verdict column reads “Not read yet”.
“They compare meaning, not words: a warning that is softened in a sentence that otherwise reads the same is still caught. You decide every deviation.”
The Label Intake Reader finds 13 local sections across the 18 pages. The Label Translator writes a back-translation of 6,120 words, 58% from translation memory, with the labeling glossary applied. The Meaning Aligner pairs all 12 CCDS meanings and finds 1 local addition and nothing missing. The Deviation Classifier and the Justification Matcher follow, each step shown as it runs.
The Label Translator never corrects a number or a unit, and the original text is always shown beside the reading.
§4.4 Liver monitoring. The CCDS says to interrupt treatment if drug-induced liver injury is suspected; bula v7 says “usar com cautela” — use with caution. The rest of the sentence is unchanged, so 85% of the words still match, but the action to stop treatment is gone. Rule R-01, unjustified · critical, confidence 0.96. No approved justification for Brazil is on file.
“85% of the words match the CCDS. A word-by-word check would pass this sentence. Read for meaning, it says something else.”
The version history shows bula v6 said “Interromper o tratamento”; the wording changed when v7 was reformatted. Maya confirms critical. The Labeling Committee, chaired by Lena Ortiz, is alerted, and task REM-BR-01 goes to Ana Ribeiro with the correction due Nov 6 — and the corrected Portuguese sentence drafted by the Remediation Drafter from the CCDS and the translation memory.
“Critical confirmed — Labeling Committee alerted, task REM-BR-01 sent to Ana Ribeiro.”
The national template moves sections: dosing sits under “8. Posologia”, the warnings under “5. Advertências”. Each CCDS meaning is paired with the local sentence that carries it and both pages are cited. Of 13 rows, 9 are aligned, 1 is an acceptable deviation and 3 are unjustified — the review shows “Sign review · 2 open”.
Every pair cites both pages.
§6.4 Storage: the bula allows room temperature up to 30 °C against 25 °C in the CCDS. JUS-BR-011 allows 30 °C in Brazil — but it was approved for Corventa tablets, not Veltrimab, so it is shown as a near match and a person decides whether it extends. In §4.8, tinea infections read uncommon where the CCDS says common: rule R-03, major. The pregnancy risk statement matches HA-BR-003 word for word and is accepted by rule.
“Near match: JUS-BR-011 … Approved for Corventa only · §6.4. It is shown, never applied.”
The Mexico IPP v4 gives the contraception period after the last dose as “al menos 8 semanas”; the CCDS says at least 18 weeks. Rule R-02 makes any changed number in a dose, interval or duration critical. IPP v3 said 18 semanas — the number changed in the v4 translation round. A driving caution added without a source is a minor deviation under R-05.
Japan's package insert v3 drops “and for at least 18 weeks after the last dose” from the live-vaccine warning. A later precaution may carry it, so confidence is 0.71 — below the 0.80 threshold. The row is marked low confidence and proposed as major under R-01b, for a person to decide between major and critical. The warning box, the percentage frequency bands and the missing driving section are acceptable deviations, each matched to HA-mandated text or a justification on file.
Below 0.80 confidence goes to a person.
After Brazil the register holds 37 entries from 21 labels: 21 acceptable with a reason on file, 11 unjustified, 5 unjustified and critical. Each names the CCDS meaning, the local wording in English, the class, the root cause, the justification or task, and its status. Sam signs and exports it before the Nov 20 inspection-readiness review.
“If it's not in the register with its evidence, it didn't happen.”
The dashboard shows the Veltrimab wave: 21 labels compared, 268 meanings, 86% saying the same as the CCDS, 37 deviations. HA-mandated text is the largest root cause and all of it is justified; the drift that needs fixing comes mostly from translation errors and affiliate edits. A market-by-meaning grid opens any label from its cell.
The same wave, seen by the five people who carry it — in their own words, and what their work looks like now.
Six agents read, back-translate, pair and classify every local label and draft each fix; the medical risk assessor decides every deviation.
Reads each local label where it lives — document type, language, version, sections and pages — and links it to the CCDS version it should follow.
Writes an English reading of the label sentence by sentence, using the translation memory and the labeling glossary; the original stays the source of truth.
Splits the CCDS and the local label into meaning units and pairs them, even when the local template reorders or merges sections; reports missing meanings and local additions.
Reads each pair for meaning, not word overlap, and proposes aligned, acceptable deviation or unjustified — critical, major or minor — with the rule that fired, the reason and a confidence.
Checks each deviation against the justification register and the HA-mandated text library for the same market, product and section; exact matches are accepted by rule.
When a person confirms a deviation, drafts the corrected local sentence in the label language and opens a task for the affiliate with the clock its risk class sets.
Decides and signs. The agents propose; a named person decides.
Ask about a market, a CCDS section, a deviation or the register — or say which rule to add. Every answer cites its sources.
Why is the Brazil liver warning critical?
The CCDS says to interrupt treatment if drug-induced liver injury is suspected. The Brazil bula v7 says “usar com cautela” — use with caution. 85% of the words still match, so a word-by-word check passes it; read for meaning, the instruction to stop treatment is gone. Rule R-01 makes a weakened warning critical. Bula v6 said “interromper o tratamento”. No justification is on file.
What did the Mexico leaflet get wrong?
Three findings in the Mexico IPP v4. The critical one: contraception after the last dose is “al menos 8 semanas” where the CCDS says at least 18 weeks — the number changed in the v4 translation round. A driving caution was added without a source (minor), and the prescription legend is justified by HA-MX-001.
Is the Brazil 30 °C storage justified?
Not yet. The bula allows up to 30 °C; the CCDS says up to 25 °C for 21 days. India and Egypt are justified at 30 °C under JUS-IN-002 and JUS-EG-001. For Brazil, JUS-BR-011 covers Corventa only, so it is a near match. You can extend JUS-BR-011 to Veltrimab with the climate-zone stability report SR-VLT-118.
Add a rule: a dropped anaphylaxis term is always critical
Done. Rule R-08 is on: when §4.8 no longer names anaphylaxis, the deviation is critical and goes to the Labeling Committee. It reclassified the open items that drop the term, such as France. The rule is in Settings and on the audit trail.
13 screens from the working solution, on its sample data. Pick one to see it large.
The rules every label is classified by, who approves what and the correction clocks are settings, on the audit trail.
| Setting | Default | Choose from |
|---|---|---|
| R-01 · a contraindication, warning or monitoring step in §4.3–4.4 missing or weakened | Critical, escalated to the Labeling Committee | On · Off |
| R-02 · a number changed in a dose, interval or duration | Critical — the number must match exactly | On · Off |
| Accept exact matches to the register by rule | On | On · Off |
| Send to a person below this confidence | 0.80 | 0.75 · 0.80 · 0.85 · 0.90 |
| Confirm a critical deviation | Medical risk assessor · Dr. Maya Chen | Dr. Maya Chen · Lena Ortiz · Sam Patel · Omar Haddad · Dana Okafor |
| Escalate a critical deviation to the Labeling Committee | 2 business days | 1 · 2 · 3 business days |
| Submit the correction — critical | 30 days | 14 · 30 · 60 days |
| Submit the correction — major | 90 days | 60 days · 90 days · Next routine update |
Every figure is labelled: a target the solution is built to, an estimate, a typical published result, or a proven one.
“demo” = seen in the working solution, on its sample labels · “target” = the design goal, measured in the live solution · “estimated” = the solution's own estimate before deployment · “typical” = published figures (Acolad, identifying local label deviations — a manual audit of about 100 countries that took 18 months). Products and people named on this page — Veltrimab, Corventa, Dr. Maya Chen, Lena Ortiz, Sam Patel, Ana Ribeiro, Diego Navarro — are fictional: characters and sample data in the working solution.
It is the check that every local label — SmPC, USPI, bula, package insert, IPP, monograph — says what the CCDS says, and that every difference has a reason on file. Local Label Deviation Review reads each label in its own language, back-translates it, pairs every sentence with its CCDS meaning and classifies each row as aligned, acceptable deviation or unjustified, for the medical risk assessor to decide.
By meaning, not by matching words. The Meaning Aligner pairs each CCDS meaning with the local sentence that carries it, wherever the national template puts it, and the Deviation Classifier reads each pair against the medical-risk rules. A sentence that keeps 85% of its words but turns “interrupt treatment” into “use with caution” is caught as critical.
Yes. Each label is read in its own language, and the Label Translator writes an English back-translation sentence by sentence with the translation memory and the labeling glossary. Numbers and units are never corrected, and the original text is always shown beside the reading. The sample wave covers 15 languages.
The Justification Matcher checks every deviation against the justification register and the HA-mandated text library for the same market, product and section. Exact matches are accepted by rule and cited. A justification approved for another product or section is shown as a near match and never applied; extending it needs evidence and the global labeling lead's approval.
The Remediation Drafter drafts the corrected sentence in the label language and opens a task for the affiliate owner with the clock its risk class sets — 30 days for a critical correction and 90 days for a major one by default. A critical deviation is escalated to the Labeling Committee. The deviation register records the class, root cause and who decided.
Yes. The agents propose and never close a critical deviation. The medical risk assessor confirms, downgrades or accepts every deviation and signs each label review; anything below the confidence threshold goes to a person; the affiliate submits the correction; and labeling compliance signs the register.
Yes. The classification rules, exact-match acceptance, the confidence threshold, who confirms, approves and signs, and the escalation and correction clocks are all settings, kept on the audit trail. New rules can be added in plain words.
The Agentic Solution Engine builds and deploys it from your requirements and documents — your CCDS, your local labels, your justification register and labeling rules — and it goes live once every quality gate has passed. We will walk you through it on your own labels first.
Every agency change reaches the right team within hours, with what changed marked.
1-min demoCTD Module 2 AuthoringModule 2 summaries drafted in weeks, every statement cited to its source.
1-min demoHealth Authority Query ResponseCited first drafts within hours, consistent with every past answer to every agency.
1-min demoWe'll run Local Label Deviation Review on your CCDS and a sample of your own local labels.